Is Nanosonics Ltd a blue-chip share of tomorrow?

The Nanosonics Ltd. (ASX:NAN) share price is rocketing today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in hospital disinfectant medical device business Nanosonics Ltd. (ASX: NAN) have lifted 3% to a record high of $2.53 this morning after the Scottish National Health Service released new guidelines supportive of the use of Nanosonics' disinfectant products.

The company sells devices for the disinfectant of ultrasound probes with some $15.5 million worth of sales in the US market for the six months ending December 31 2016. It has also now delivered consecutive quarter-on-quarter sales growth for the past four quarters after deciding to sell its products in North American markets directly rather than via wholesale distributors.

In response the share price has lifted 42% over the past year as sales momentum builds and the company's global horizons expand, with today's news from Scotland a boost to potential sales growth.

The company is also waiting on potential new guidelines from national health services in England, Wales and France, with large healthcare markets in Asia like Korea and Japan other potential targets.

For the most recent six-month period the firm posted a net loss of $3.2 million, although it has $42.6 million cash on the balance sheet to fund marketing, research and product development.

It also has a management team that can draw from the success of blue-chip medical devices businesses on the ASX like Cochlear Limited (ASX: COH) and ResMed Inc. (CHESS) (ASX: RMD).

Notably, Nanosonics' CEO is a  former employee of Cochlear's Global Marketing division. While its Head of Global Marketing is a former employee of both Cochlear and ResMed, which suggests the company could follow a proven path to blue-chip success.

For growth-oriented investors willing to take on some extra risk the business ticks all the boxes except perhaps valuation, which is high given the market capitalisation around $725 million. Evidently the market is expecting strong sales growth and some blockbuster success, which is possible, but far from guaranteed at this stage in its development.

Motley Fool contributor Tom Richardson owns shares of ResMed Inc.. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »